See the DrugPatentWatch profile for delgocitinib
What is US10822354B2 about (and how does it relate to delgocitinib)?
US10822354B2 is a U.S. patent record that can be searched on Google Patents by entering the number directly. The number itself does not, by default, reveal from plain text what the document covers, but it is the right starting point to pull the title, assignee, abstract, and claim language from the Google Patents page.
If your goal is to find “the delgocitinib process patent” specifically, the fastest path on Google Patents is:
- search US10822354B2 to open the patent
- check the “Title” and “Abstract”
- scan the “Claims” for terms like “delgocitinib,” “JTE-052,” “formulation,” “process,” “preparation,” or specific reaction steps
How to find “the process” claims inside US10822354B2 on Google Patents
Once on the Google Patents page for US10822354B2, use these in-page cues to identify the process coverage:
- Claims containing verbs such as “preparing,” “reacting,” “reacting under,” “hydrogenating,” “crystallizing,” “isolating,” or “purifying” typically indicate manufacturing or formulation steps.
- If the patent is about a chemical or drug substance, look for claims describing:
- synthetic route steps (starting materials to intermediates to final compound)
- purification/crystallization of delgocitinib
- making a salt, polymorph, or solid form
- The “Description” section usually provides the detailed sequence that the claims summarize.
Who owns/assignees US10822354B2 and why that matters for delgocitinib
For patent relevance (licenses, enforcement risk, and whether it targets delgocitinib specifically), the assignee listed on Google Patents is critical. It helps determine:
- whether the document is filed by the original innovator or a manufacturing/formulation partner
- which companies may be enforcing related delgocitinib IP
- whether there are related continuations or family members in other jurisdictions
On Google Patents, look at the “Assignee” line and also the “Patent family” panel (if present).
How to confirm whether this patent is specifically “delgocitinib” versus a related JAK inhibitor
Even when a patent number is being discussed as a “delgocitinib process patent,” you should confirm it directly in the document:
- Search within the page for “delgocitinib”
- If delgocitinib is not named, the document might cover a broader class of compounds, intermediates, or general manufacturing steps applicable to multiple agents.
- Claims may refer to “a compound of Formula (I)” and define the compound structurally. In that case, the question becomes whether delgocitinib matches that structural formula.
Can you use Google Patents to find the whole family (and find the true “process” patent)?
Often, the “process” counterpart is in a different publication in the same family. On Google Patents:
- open the “Patent family” section
- check for related publications (U.S. continuations, PCT entries, EP/WO counterparts)
- look for titles that mention “process for preparing,” “manufacturing method,” “intermediate,” or “formulation”
If US10822354B2 is not the process document you expected, the family view usually leads to the correct one.
What you can tell me to get a precise answer
If you paste the Google Patents text for any of the following from US10822354B2, I can map it tightly to “delgocitinib process” coverage:
- the title and abstract
- 1–3 independent claims (the main numbered claims)
- the assignee and earliest priority date
- the first representative example/reaction in the description
Source
No sources were provided with your message, and I can’t open Google Patents directly from here. If you share the Google Patents link or the claim/title text, I can produce an exact, claim-level summary of the delgocitinib “process” aspects for US10822354B2.